An experimental study on the therapeutic efficacy of the combined administration of herbal medicines with atorvastatin against hyperlipidemia in rats

Journal of Applied Sciences Research

Volumn 6, Issue 11, 2010, Pages 1730-1744

  Raouf Hamed, M ^a   Hassanein, Nahed M A ^a   Ali, Azza A ^b   El Nahhas, Toqa M Y ^a  

^a National Organization for Drug Control And Research (NODCAR)   (Saudi Arabia)

^b Al Azhar University   (Saudi Arabia)

Author keywords

Atorvastatin; Capsaicin; Garlic; Guggulipid; Hyperlipidemia

Indexed keywords

EID: 78650485637     PISSN: 1816157X     EISSN: 1819544X     Source Type: Journal    
DOI: None     Document Type: Article

References (90)

1. Steiner, G., 1996. The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health Organization. Diabetologia, 39: 1655-1661.
2. Ural, A.U. and F. Avcu, 2006 HMG-CoA reductase inhibitors may affect thrombin generation by reducing factor VII activity in hyperlipidemic patients. Thrombosis Research, 118: 665-666.
3. Hunninghake, D., W. Insull, R. Knopp, M. Davidson, L. Lohrbauer, P. Jones and S. Kafonek, 2001. Comparison of the efficacy of atorvastatin versus cerivastatin in primary hypercholesterolemia. Am. J. Cardiol., 88: 635-639.
4. Schaefer, E.J., J.R. McNamara, T. Tayler, J.A. Daly, J.L. Gleason, L.J. Seman, A. Ferrari, and J.J Rubenstein, 2004. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin)on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects. Am. J. Cardiol., 93(1):31-9.
5. Hodel, C., 2002. Myopathy and rhabdomyolysis with lipid-lowering drugs. Toxicology Letters, 128: 159-168.
6. Thompson, P.D., P. Clarkson and R.H. Karas, 2003. Statin-associated myopathy. JAMA., 289(13): 1681-90.
7. Srinivasan, M.R. and M.N. Satyanarayana, 1989. Effect of capsaicin on skeletal muscle lipoprotein lipase in rats fed high fat diet. Indian Journal of Experimental Biology, 27(10): 910-912.
8. Lata, S., K.K. Saxena, V. Bhasin, R.S. Saxena, A. Kumar and V.K. Srivastava, 1991. Beneficial effects of Allium sativum, Allium cepa and Commiphora mukul on experimental hyperlipidemia and atherosclerosis-a comparative evaluation. J. Postgrad. Med., 37(3):132-5.
9. Lin, M C., E.J. Wang, C. Lee, K.T Chin, D. Liu, J. Chiu and H. Kung, 2002. Garlic inhibits microsomal triglyceride transfer protein gene expression in human liver and intestinal cell lines and in rat intestine. J. Nutr., 132: 1165-1168.
10. Yadav, R.K. and N.S. Verma, 2004. Effect of garlic (Allium sativum) extract on the heart rate, rhythm and force of contraction in frog: A dose dependent study. Ind. J. Exp.Biol., 42(6): 628-631.
11. Chander, R., F. Rizvi, A.K. Khanna and R. Pratap, 2003. Cardioprotective activity of synthetic guggulsterone (E and Zisomers) in isoproterenol induced myocardial ischemia in rats: A comparative study. Indian J. Clin. Biochem., 18: 71-79.
12. Deng, R., 2007. Therapeutic Effects of Guggul and Its Constituent Guggulsterone: Cardiovascular Benefits. Cardiovasc. Drug Rev., 25(4):375-90.
13. Singh, R.B., M.A. Niaz and S. Ghosh, 1994. Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc. Drugs Ther., 8: 659-664.
14. Panda, S. and A. Kar, 1999. Gugulu (commiphora mukul) induces triiodothyronine production: possible involvement of lipid peroxidation. Life Sci., 65(12):PL137-41.
15. Kempaiah, R.K. and K. Srinivasan, 2006. Beneficial influence of dietary curcumin, capsaicin and garlic on erythrocyte integrity in high-fat fed rats. J. Nutr. Biochem., 17(7):471-8.
16. Srinivasan, K., 2005. Spices as influencers of body metabolism: an overview of three decades of research. Food Research International, 38(1):77-86.
17. Pedrosa, R.C., C. Meyre-Silva, V. Cechinel-Filho, J.C. Benassi, L.F. Oliveira, V. Zancanaro, J. Dal Magro and R.A. Yunes, 2002. Hypolipidaemic activity of methanol extract of Aleurites moluccana. Phytother. Res., 16(8):765-8.
18. Bamji, M.S.and D. Sharada, 1972. Hepatic glutathione reductase and riboflavin concentrations in experimental deficiency of thiamin and riboflavin in rats. J. Nutr., 102(3):443-447.
19. Schmechel, A., M. Grimm, A. El-Armouche, G. Höppner, A.P. Schwoerer, H. Ehmke, and Eschenhagen, T. 2009. Treatment with atorvastatin partially protects the rat heart from harmful catecholamine effects. Cardiovascular Research, 82(1):100-106.
20. Banerjee, S.K., M. Maulik, S.C. Mancahanda, A.K. Dinda, S.K. Gupta and S.K. Maulik, 2002. Dose-dependent induction of endogenous antioxidants in rat heart by chronic administration of garlic. Life Sci., 70(13):1509-18.
21. Thomson, M., K.K. Al-Qattan, T. Bordia, Ali, and M, 2006. Including garlic in the diet may help lower blood glucose, cholesterol and triglycrides. J.Nutr. 136:800s-802s.
22. Lee, C.J., M. Kim, S. Yoon and C. Lee, 2003. Short-term Control of Capsaicin on Blood and Oxidative Stress of Rats in vivo. Phytother, Res.,17:454-458.
23. Allain, C.C., L.S. Poon, C.S.G. Chan, W. Richmond and P.C. Fu, 1974. Enzymatic Determination of Total Serum Cholesterol. Clinical Chemistry, 20:470-475.
24. Fossati, P. and L. Prencipe, 1982. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clinical Chemistry, 28:2077-2080.
25. Assmann, G., H.U. Jabs, U. Kohnert, W. Nolte and H. Schriewer, 1984. LDL-cholesterol determination in blood serum following precipitation of LDL with polyvinylsulfate. Clin. Chim. Acta., 140(1):77-83.
26. Lopes-Virella, M.F., P. Stone, S.Ellis and J.A. Colwell, 1977. Cholesterol determination in high-density lipoproteins separated by three different methods. Clinical Chemistry, 23: 882-884.
27. Reitman, S. and S. Frankel, 1957. Colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am. J. Clin. Pathol., 28:56.
28. Tholstrup, T., P. Marckmann, B. Vessby, and B. Sandstrom, 1995. Effect of fats high in individual saturated fatty acids on plasma lipoprotein a levels in young healthy men. J. Lipid Res., 36: 1447-1452.
29. Uchida, K., Y. Nomura, M. Kadowaki, N. Takeuchi and Y. Yamamura, 1977. Effect of Dietary Cholesterol on Cholesterol and Bile Acid Metabolism in Rats.The Japanese Journal of Pharmacology, 27(2):193-204.
30. Bradley-Hillgartner, F., L.M. Salati and G. Goodridge, 1995. Physiological and molecular mechanisms involved in nutritional regulation of fatty acid synthesis. Physiol. Rev., 75:47-76.
31. Arner, P., H. Wahrenberg, F. Lonnqvist and B. Angelin, 1993. Adipocyte β2-adrenoceptor sensitivity influences plasma lipid levels. Arterioscler. Thromb. 13: 967-972.
32. Reynisdottir, S., M. Eriksson, B. Angelin, and P. Amer, 1995. Impaired Activation of Adipocyte Lipolysis in Familial Combined Hyperlipidemia. J. Clin. Invest., 95:2161-2169.
33. Spady, D.K. and J. M. Dietschy, 1985. Dietary saturated triacylglycerols suppress hepatic low density lipoprotein receptor activity in the hamster. Proc. Natl. Acad. Sci. U S A., 82(13):4526-30.
34. Stucchi, A.F., Terpstra, A.H.M. and Nicolosi, R.J. (1995): LDL receptor activity is down-regulated similarly by a cholesterol-containing diet high in palmitic acid or high in lauric and myristic acids in cynomolgus monkeys. J. Nutr., 125: 2055-2063.
35. Mustad, V.A., T.D. Etherton, A.D. Cooper, Mastro, A.M., Pearson, T.A., Jonnalagadda, S.S. and Kris-Etherton, P.M. (1997): Reducing saturated fat intake is associated with increased levels of LDL receptors on mononuclear cells in healthy men and women. Journal of Lipid Research, 38: 459-468.
36. Bakker-Arkema, R.G., J., Best, R. Fayyad, T.M. Heinonen, A.D. Marais, J.W. Nawrocki and D.M. Black, 1997. A brief review paper of the efficacy and safety of atorvastatin in early clinical trials. Atherosclerosis, 131(1):17-23.
37. Blum, C.B.B., 1994. Cornparison of properities of four inhibitors of 3-hydroxy-3-methyglutarylcoenzyme A reductase. Am. J. Cardiol., 73(14):3D-11D.
38. Rackley, C.E., 1996. Monotherapy with HMG-CoA reductase inhibitors and secondary prevention in coronary artery disease. Clin. Cardiol., 19:683-689.
39. Miettinen, T.A. 1991. Inhibition of cholesterol absorption by HMG-CoA reductase inhibitor. Eur. J. Clin. Pharmacol., 40(Suppl 1):S19-S21.
40. Banerjee, S.K. and S.K. Maulik, 2002. Effect of garlic on cardiovascular disorders: a review. Nutr. J., 1-4.
41. Nwanjo, H.U. and G.O. Oze, 2007. Antiarrythmic and anti-hyperlipidaemic potentials of aqueous garlic extract in hypercholesterolaemic rats. The Internet Journal of Nutrition and Wellness™ ISSN: 1937-8297.
42. Yeh, Y.Y. and L. Liu, 2001. Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies. J. Nutr.,131(3s):989S-93S.
43. Larner, A.J., 1995. How does garlic exert its hypocholesterolaemic action? The tellurium hypothesis. Med. Hypotheses, 44(4):295-7.
44. Effraim, K.D., S. Modu, and H.G. Hamzah, 2000. Effect of crude garlic extract on nicotine induced hyperglycaemia and hyperlipidemia in rats. Afr. J. Biomed. Res., 3:125-127.
45. Augusti, K.T., C. Ashakumari, G. Daniel, S. Jaya, S.K. Mathew, A. Sreerekha and P.K. Joseph, 2008. The beneficial effects of garlic oil and garlic cake on coconut oil fed rats. Journal of Medicinal Plants Research 2(2):034-038.
46. Kumari, K. and K.T. Augusti, 2007. Lipid lowering effect of S-methyl cysteine sulfoxide from Allium cepa Linn in high cholesterol diet fed rats. J. Ethnopharmacol., 109:367-371.
47. Chi, M.S., E.T. Koh and T.J. Stewart, 1982. Effect of garlic on lipid metabolism in rats fed cholesterol or lard. J. Nutr., 112:241-248.
48. Adler, A.J. and B.J. Holub, 1997. Effect of garlic and fish-oil supplementation on serum lipid and lipoprotein concentrations in hypercholesterolemic men. Am. J. Nutr., 65:445-50.
49. Kojuri, J., A.R. Vosoughi and M. Akrami, 2007. Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients. Lipids Health Dis., 6:5.
50. Sambaiah, K. and M.N. Satyanarayana, 1980 Hypocholesterolemic effect of red pepper & capsaicin. Indian J. Exp. Biol. 18(8):898-9.
51. Sambaiah, K. and M.N. Satyanarayana, 1982. Influence of red pepper and capsaicin on body composition and lipogenesis in rats. Journal of Bioscience, 4(4):425-430.
52. Tani, Y., T. Fujioka, M. Sumioka, Y. Furuichi, H. Hamada and T. Watanabe, 2004. Effects of capsinoid on serum and liver lipids in hyperlipidemic rats. J. Nutr. Sci. Vitaminol. (Tokyo). 50(5):351-5.
53. Brown, M.S., P.T. Kovanen and J.L. Goldstein, 1981. Regulation of plasma cholesterol by lipoprotein receptors. Science, 212(4495):628-35.
54. Angelin, B., C.A. Raviola, T.L.Innerarity and R.W. Mahley, 1983. Regulation of hepatic lipoprotein receptors in the dog. Rapid regulation of apolipoprotein B,E receptors, but not of apolipoprotein E receptors, by intestinal lipoproteins and bile acids. J. Clin. Invest. 71(4):816-31.
55. Ohnluki, K., S. Haramizu, T. Watanabe, S. Yazawa and Fushiki, T. T Fushiki,2001. CH-19 sweet, nonpungent cultivar of red pepper, increased body temperature in mice with vanilloid receptors stimulation by capsiate. J. Nutr. Sci. Vitaminol., (Tokyo). 47(4):295-8.
56. Morimoto, C., K. Kameda, T. Tsujita and H. Okuda, 2001. Relationships between lipolysis induced by various lipolytic agents and hormone-sensitive lipase in rat fat cells. Journal of Lipid Research, 42(1):120-127.
57. Manjunatha, H. and K. Srinivasan, 2008. Hypolipidemic and antioxidant potency of heat processed turmeric and red pepper in experimental Rats. African Journal of Food Science. 2:1-6.
58. Urizar, N.L. and Moore, D.D. (2003): Gugulipid: a natural cholesterol-lowering agent. Ann. Rev. Nutr., 23:303-13.
59. Ulbricht, C., E. Basch, P. Szapary, P. Hammerness, S. Axentsev, H. Boon, D. Kroll, L. Garraway, M. Vora and J. Woods, 2005. Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration. Complement Ther. Med.., 13(4):279-90.
60. Sheela, C.G. and K.T. Augusti, 1995. Effects of S-allyl cysteine sulfoxide isolated from Allium sativum Linn and gugulipid on some enzymes and fecal excretions of bile acids and sterols in cholesterol fed rats. Indian J. Exp. Biol., 33(10):749-51.
61. Datta, S., L. Wang, D.D. Moore and T.F. Osborne, 2006. Regulation of 3-hydroxy-3- methylglutaryl coenzyme A reductase promoter by nuclear receptors liver receptor homologue-1 and small heterodimer partner: a mechanism for differential regulation of cholesterol synthesis and uptake. J. Biol. Chem., 281: 807-812.
62. Hubbert, M.L., Y. Zhang, F.Y. Lee and P.A. Edwards, 2007. Regulation of hepatic Insig-2 by the farnesoid X receptor. Mol. Endo., 21(6): 1359-1369.
63. Singh, V., S. Kaul, R. Chander and N.K. Kapoor, 1990. Stimulation of low density lipoprotein receptor activity in liver membrane of guggulsterone treated rats. Pharmacol. Res., 22(1):37-44.
64. Nakahara, M., H. Fujii, P.R. Maloney, M. Shimizu and R. Sato, 2002. Bile acids enhance low density lipoprotein receptor gene expression via a MAPK cascade-mediated stabilization of mRNA. J. Biol. Chem., 277(40):37229-37234.
65. Lambert, G., M.J. Amar, G. Guo, H.B. Brewer, F.J. Gonzalez and C.J. Sinal, 2003. The farnesoid X-receptor is an essential regulator of cholesterol homeostasis. J. Biol. Chem., 278(4):2563-2570.
66. Langhi, C., C. Le May, S. Kourimate, S. Caron, B. Staels, M. Krempf, P. Costet and B. Cariou, 2008. Activation of the farnesoid X receptor represses PCSK9 expression in human hepatocytes. FEBS Lett., 582:949-955.
67. Urizar, N.L., A.B. Liverman, D.T. Dodds, F.V. Silva, P. Ordentlich, Y. Yan, F.J. Gonzalez,R.A. Heyman, D.J. Mangelsdorf and D.D. Moore, 2002. A natural product that lowers cholesterol as an antagonist ligand for FXR. Science, 296(5573):1703-6.
68. Wu, J., C. Xia, J. Meier, S. Li, X. Hu and D.S. Lala, 2002. The hypolipidemic natural product guggulsterone acts as an antagonist of the bile acid receptor. Mol. Endocrinol., 16:1590-1597.
69. Deng, R., D. Yang, A. Radke, J. Yang and B. Yan, 2007. The hypolipidemic agent guggulsterone regulates the expression of human bile salt export pump: dominance of transactivation over farsenoid X receptor-mediated antagonism. J. Pharmacol. Exp. Ther., 320(3):1153-62.
70. Lacko, A.G., S.M. Lee, I. Mirshahi, J. Hasler-Rapacz, B.J. Kudchodkar and J. Rapacz, 1992. Decreased lecithin-cholesterol acyltransferase activity in the plasma of hypercholesterolemic pigs. Lipids 27:266-269.
71. Shepherd, J., 1994. Lipoprotein metabolism: an overview. Drugs 47:1-10.
72. Tall, A. R., 1990. Plasma high density lipoproteins metabolism and relationship to atherogenesis. J. Clin. Invest., 86(2):379-384.
73. Srinivasan, M. R. and M.N. Satyanarayana, 1992. Comparative influence of vanillin and capsaicin on liver and blood lipids in the rat. Indian J. Med. Res., 96:133-5.
74. Lablanche, J.M., 2001. Achieving LDL-C Target Levels: The Role of Statins. Curr. Med. Res. Opin., 16(4):285-95.
75. Kliewer, S.A., H.E. Xu, M.H. Lambert, and T.M. Willson, 2001. Peroxisome proliferator-activated receptors: from genes to physiology. Recent. Prog. Horm. Res., 56:239-263.
76. Bolkent, S., R. Yanardag, O. Karabulut-Bulan and B. Yesilyaprak, 2005. Protective role of Melissa officinalis L. extract on liver of hyperlipidemic rats: A morphological and biochemical study. Journal of Ethnopharmacology, 99(3):391-398.
77. Amin, K.A. and T.M. Abd El-Twab, 2009. Oxidative markers, nitric oxide and homocysteine alteration in hypercholesterolimic rats: role of atorvastatine and cinnamon. Int. J. Clin. Exp. Med., 2(3):254 -65.
78. Prasad, K. and J. Kalra, 1989. Experimental atherosclerosis and oxygen free radicals. Angiology, 40(9):835-43.
79. Bolkent, S., R. Yanardag, S. Bolkent, and M.M. Doger, 2004. Beneficial effects of combined treatment with niacin and chromium on the liver of hyper-lipemic rats. Biol. Trace Elem. Res., 101(3): 219-29.
80. Abdel-Rahman, M.K., E.M. Mahmoud, A.R. Abdel-Moemin and O.G.A.Rafaat, 2009. Re-evaluation of individual and combined garlic and flaxseed diets on hyperlipidemic rats. Pakistan Journal of Nutrition, 8(1): 1-8.
81. Borek, C., 2001. Antioxidant health effects of age garlic extract. The Journal of Nutrition, 131: 1010S-1015S.
82. Imai, J., N. Ide, S. Nagae, T. Moriguchi, H. Matsuura and Y. Itakura, 1994. Antioxidant and radical scavenging effects of aged garlic extract and its constituents. Planta Med., 60(5):417-420.
83. Geng, Z. and B. Lau, 1997. Aged garlic extract modulates glutathione redox cycle and superoxide dismutase activity in vascular endothelial cells. Phytother. Res., 11:54-56.
84. Banerjee, S.K., M. Maulik, S.C. Manchanda, A.K. Dinda, T.K. Das and S.K. Maulik, 2001. Garlic-induced alteration in rat liver and kidney morphology and associated changes in endogenous antioxidant status. Food Chem. Toxicol., 39(8):793-797.
85. Kumar, V., P. Singh, R. Chander, F. Mahdi, S. Singh, R. Singh, A.K. Khanna, J.K. Saxena, A.A. Mahdi and V.K. Singh, 2009. Hypolipidemic activity of Hibiscus rosa sinensis root in rats. Indian J. Biochem. Biophys., 46(6):507-10.
86. Manjunatha, H., and K. Srinivasan, 2007. Hypolipidemic and antioxidant effects of curcumin and capsaicin in high-fat-fed rats. Can. J. Physiol. Pharmacol., 85(6):588-96.
87. Contestabile, A., 2001. Oxidative stress in neurodegeneration: mechanisms and therapeutic perspectives. Curr. Top. Med. Chem., 1(6):553-568.
88. Martín-Castillo, A., M.T. Castells, G. Adánez, M.T. Polo, B.G. Pérez and I. Ayala, 2010. Effect of atorvastatin and diet on non-alcoholic fatty liver disease activity score in hyperlipidemic chickens. Biomed. Pharmacother., 64(4):275-81.
89. Kawada, T., T. Watanabe, T. Takaishi, T. Tanaka, and K. Iwai, 1986. (a)Capsaicin-induced beta-adrenergic action on energy metabolism in rats: influence of capsaicin on oxygen consumption, the respiratory quotient, and substrate utilization. Proc. Soc. Exp. Biol. Med., 183(2):250-256.
90. Kawada, T., K. Hagihara and K. Iwai, 1986.(b) Effects of capsaicin on lipid metabolism in rats fed a high fat diet. J. Nutr., 116:1272-1278.